Human Cav1.2/CACNA1C Blocking Peptide (#BLP-CC022) is the original antigen used for immunization during Anti-Human CaV1.2 (CACNA1C) Antibody (#ACC-022) generation. The blocking peptide binds and 'blocks' Anti-Human Cav1.2/CACNA1C primary antibody, this makes it a good negative reagent control to help confirm antibody specificity in western blot and immunohistochemistry applications. This control is also often called a pre-adsorption control.
Reconstitution
100 ul double distilled water (DDW)
Formulation
Lyophilized Powder.
Accession Number
BLP
Concentration
0.4 mg/ml.
Form
Lyophilized powder
Notes
Peptide confirmation: Confirmed by amino acid analysis and mass spectrometry Is Toxin: No Standard quality control of each lot: Western blot analysis. Antibodies part of immunogen: VNENTRMYIPEENHQ(C), corresponding to amino acid residues 2-15 of human CaV1.2 (exon 1B) Antigen preadsorption control: 1 ug peptide per 1 ug antibody
UNSPSC Code
41105329
Lead Time
1-2 Business Days
Gene Id
775
Sequence
VNENTRMYIPEENHQ(C), corresponding to amino acid residues 2-15 of human CaV1.2 (exon 1B)
Target
CACNA1C
Country Of Origin
Israel/IL
Shipping
Shipped at room temperature. Product as supplied can be stored intact at room temperature for several weeks. For longer periods, it should be stored at -20°C
Purity
>70%
Storage
Storage After Reconstitution: -20°C. Storage Before Reconstitution: Lyophilized powder can be stored intact at room temperature for two weeks. For longer periods, it should be stored at -20°C